Literature DB >> 8645223

KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.

M Ichimura1, R Eiki, K Osawa, S Nakanishi, H Kase.   

Abstract

The effects of KS-505a, a novel microbial metabolite, on the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase (CaM-PDE) were investigated. (1) KS-505a potently inhibited the purified 61 kDa isoenzyme of CaM-PDE from bovine brain and required much higher doses to inhibit the purified 59 kDa isoenzyme of CaM-PDE from bovine heart. The inhibition of both isoenzymes was observed only in the presence of calcium-activated calmodulin (Ca2+/CaM). The IC50 values for the 61 and 59 kDa isoenzymes were 0.17 and 13 microM respectively with 20 microM cAMP as a substrate. (2) Kinetic analysis indicated that the inhibitory mode of KS-505a for the 61 kDa isoenzyme was competitive with respect to Ca2+/CaM; the K1 for KS-505a was 0.089 microM. The inhibition was not competitive with respect to the substrates cAMP or cGMP. (3) KS-505a did not interfere with the interaction between Ca2+/CaM and n-phenyll-naphthylamine, a hydrophobic fluorescent probe, nor was it adsorbed to CaM-conjugated gels in the presence of Ca2+, thereby indicating that KS-505a does not bind to Ca2+/CaM. (4) Trypsin-activated 61 kDa isoenzyme, which lacked the Ca2+/CaM-binding domain, was not inhibited by KS-505a at less than micromolar concentrations. Taken together, these results suggest that KS-505a apparently bound to a site in the Ca2+/CaM-binding domain of the 61 kDa isoenzyme and selectively inhibited Ca2+/CaM-activated 61 kDa isoenzyme activity. (5) In rat hippocampal slices, KS-505a at 10 micronM increased the intracellular cAMP concentration to approximately three times the basal level, whereas in rat striatal slices it had no effect on the cAMP concentration at concentrations of 1.0-10 microM, suggesting that each CaM-PDE isoenzyme functions differentially in these regions. These results demonstrate that KS-505a is a highly potent selective inhibitor both in vitro and in vivo and distinguishes between subfamily members within the CaM-PDE family.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645223      PMCID: PMC1217340          DOI: 10.1042/bj3160311

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  KS-505a, a novel inhibitor of bovine brain Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Streptomyces argenteolus.

Authors:  S Nakanishi; K Osawa; Y Saito; I Kawamoto; K Kuroda; H Kase
Journal:  J Antibiot (Tokyo)       Date:  1992-03       Impact factor: 2.649

2.  Molecular cloning of cDNA encoding a "63"-kDa calmodulin-stimulated phosphodiesterase from bovine brain.

Authors:  J K Bentley; A Kadlecek; C H Sherbert; D Seger; W K Sonnenburg; H Charbonneau; J P Novack; J A Beavo
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

3.  Molecular cloning of DNA encoding a calmodulin-dependent phosphodiesterase enriched in striatum.

Authors:  J W Polli; R L Kincaid
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  Sequence comparison of the 63-, 61-, and 59-kDa calmodulin-dependent cyclic nucleotide phosphodiesterases.

Authors:  J P Novack; H Charbonneau; J K Bentley; K A Walsh; J A Beavo
Journal:  Biochemistry       Date:  1991-08-13       Impact factor: 3.162

5.  Evidence for domain organization within the 61-kDa calmodulin-dependent cyclic nucleotide phosphodiesterase from bovine brain.

Authors:  H Charbonneau; S Kumar; J P Novack; D K Blumenthal; P R Griffin; J Shabanowitz; D F Hunt; J A Beavo; K A Walsh
Journal:  Biochemistry       Date:  1991-08-13       Impact factor: 3.162

Review 6.  Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.

Authors:  C D Nicholson; R A Challiss; M Shahid
Journal:  Trends Pharmacol Sci       Date:  1991-01       Impact factor: 14.819

7.  Molecular cloning of a cDNA encoding the "61-kDa" calmodulin-stimulated cyclic nucleotide phosphodiesterase. Tissue-specific expression of structurally related isoforms.

Authors:  W K Sonnenburg; D Seger; J A Beavo
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

8.  Inhibition by new anthraquinone compounds, K-259-2 and KS-619-1, of calmodulin-dependent cyclic nucleotide phosphodiesterase.

Authors:  Y Matsuda; S Nakanishi; K Nagasawa; H Kase
Journal:  Biochem Pharmacol       Date:  1990-03-01       Impact factor: 5.858

9.  A polymerase chain reaction strategy to identify and clone cyclic nucleotide phosphodiesterase cDNAs. Molecular cloning of the cDNA encoding the 63-kDa calmodulin-dependent phosphodiesterase.

Authors:  D R Repaske; J V Swinnen; S L Jin; J J Van Wyk; M Conti
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

10.  Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase.

Authors:  R L Kincaid; I E Stith-Coleman; M Vaughan
Journal:  J Biol Chem       Date:  1985-07-25       Impact factor: 5.157

View more
  3 in total

1.  A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression.

Authors:  P Calabresi; P Gubellini; D Centonze; G Sancesario; M Morello; M Giorgi; A Pisani; G Bernardi
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  Systemic immunoresponses in mice after repeated exposure of lungs to spores of Streptomyces californicus.

Authors:  J Jussila; J Pelkonen; V-M Kosma; J Mäki-Paakkanen; H Komulainen; M-R Hirvonen
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

Review 3.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.